The global recombinant DNA technology market is estimated to be valued at US$ 156.89 Mn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Recombinant DNA technology allows for efficient production of medically important compounds...
Recombinant Technology market report consists of explicit and up to date information about the consumer’s demands, their inclinations, and their variable likings about particular product. The report is a professional, all-inclusive study on the present state of the Healthcare industry with a focus on the global market. This helps businesses map the...
Analysts expect the global Hemophilia A and B Recombinant Factor Replacement Therapy market to grow at a 5.23% CAGR over the period 2022-2029.
Overview of the Market
The Hemophilia A and B Recombinant Factor Replacement Therapy Market 2022-2029 Report offers a comprehensive assessment of the market. It provides detailed analysis through qualitative insights, historical data and sustainable...
The growth of Recombinant DNA Technology market is supported by factors such as expanding application portfolio, efforts of market players through innovation and geographical penetration and so on. Strategic ties between the ecosystem participants of industry makes the market more dynamic. Recombinant DNA Technology market is expected to witness constant growth during the forecast period....
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian